NDC 64406-922
ALPROLIX
Coagulation Factor Ix (recombinant), Fc Fusion Protein
ALPROLIX is a Intravenous Kit in the Plasma Derivative category. It is labeled and distributed by Biogen Inc.. The primary component is .
| Product ID | 64406-922_39f5f856-b6e2-4aa3-bcdb-2cc97d2f948d |
| NDC | 64406-922 |
| Product Type | Plasma Derivative |
| Proprietary Name | ALPROLIX |
| Generic Name | Coagulation Factor Ix (recombinant), Fc Fusion Protein |
| Dosage Form | Kit |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2014-05-05 |
| Marketing End Date | 2021-04-30 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125444 |
| Labeler Name | Biogen Inc. |
| Active Ingredient Strength | 0 |
| NDC Exclude Flag | N |
Packaging
NDC 64406-922-01
1 KIT in 1 KIT (64406-922-01) * 5 mL in 1 VIAL (64406-954-09) * 5 mL in 1 VIAL (64406-045-01)
| Marketing Start Date | 2014-05-05 |
| Marketing End Date | 2021-04-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 64406-922-01 [64406092201]
ALPROLIX KIT
| Marketing Category | BLA |
| Application Number | BLA125444 |
| Product Type | PLASMA DERIVATIVE |
| Billing Unit | EA |
| Marketing Start Date | 2014-05-05 |
| Inactivation Date | 2020-01-31 |
Drug Details
NDC Crossover Matching brand name "ALPROLIX" or generic name "Coagulation Factor Ix (recombinant), Fc Fusion Protein"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 64406-911 | ALPROLIX | Coagulation Factor IX (Recombinant), Fc Fusion Protein |
| 64406-922 | ALPROLIX | Coagulation Factor IX (Recombinant), Fc Fusion Protein |
| 64406-933 | ALPROLIX | Coagulation Factor IX (Recombinant), Fc Fusion Protein |
| 64406-944 | ALPROLIX | Coagulation Factor IX (Recombinant), Fc Fusion Protein |
| 64406-966 | ALPROLIX | Coagulation Factor IX (Recombinant), Fc Fusion Protein |
| 64406-977 | ALPROLIX | Coagulation Factor IX (Recombinant), Fc Fusion Protein |
| 71104-911 | ALPROLIX | Coagulation Factor IX (Recombinant), Fc Fusion Protein |
| 71104-922 | ALPROLIX | Coagulation Factor IX (Recombinant), Fc Fusion Protein |
| 71104-933 | ALPROLIX | Coagulation Factor IX (Recombinant), Fc Fusion Protein |
| 71104-944 | ALPROLIX | Coagulation Factor IX (Recombinant), Fc Fusion Protein |
| 71104-966 | ALPROLIX | Coagulation Factor IX (Recombinant), Fc Fusion Protein |
| 71104-977 | ALPROLIX | Coagulation Factor IX (Recombinant), Fc Fusion Protein |
Trademark Results [ALPROLIX]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ALPROLIX 86310233 4671660 Live/Registered |
BIOVERATIV THERAPEUTICS INC. 2014-06-16 |
 ALPROLIX 85411805 4593229 Live/Registered |
BIOVERATIV THERAPEUTICS INC. 2011-08-31 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.